Company intelligence / Profile preview

RTOG Foundation

Philadelphia, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

RTOG Foundation leads and coordinates multi-center clinical trials in oncology, focusing on practice-changing protocols in radiotherapy and assessing new systemic and targeted therapies in combination with radiotherapy. Numerous trials have impacted standards of care for solid tumors; results have shaped treatments in brain, head/neck, lung, GI, GU, breast, and gynecologic cancers

Therapeutic areas: Oncology
Modalities: RadiotherapySmall moleculeBiologicTargeted therapy
Industry: Academic Hospital/University/Research

Partnerships

NRG Oncology (joint venture with NSABP and GOG Foundations for NCI clinical trials)American College of Radiology

Beyond the preview

Go deeper on RTOG Foundation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RTOG Foundation.

Explore the full profile